Table 3

Baseline characteristics of the propensity-matched cohort with aortic PVL

CharacteristicsSAVR
(n=86)
TAVR
(n=86)
Standardised mean differenceP values
Clinical data
 Age, years77±1178±90.140.37
 Male sex55 (64)57 (66)0.050.75
 Median STS score (IQR), %5.0 (3.0–7.0)4.9 (3.0–8.0)0.050.75
 Aortic stenosis as procedural indication86 (100)86 (100)
 PVL severity
  Trivial or mild PVL75 (87)72 (84)0.100.52
  Greater than mild PVL11 (13)14 (16)
 NYHA class III or IV72 (84)71 (83)0.030.84
 Atrial fibrillation30 (35)24 (28)0.150.32
 Diabetes26 (30)38 (44)0.290.06
 Hypertension69 (80)79 (92) 0.34 0.03
 Coronary artery disease64 (74)63 (73)0.030.86
 Triple vessels coronary artery disease32 (37)38 (44)0.140.35
 Previous CABG48 (56)46 (53)0.050.76
 Prior cerebrovascular accident11 (13)12 (14)0.030.82
 Peripheral vascular disease25 (29)29 (34)0.100.51
 Creatinine level, mg/dL1.22±0.751.22±0.700.010.99
 History of endocarditis0 (0)0 (0)
 Chronic obstructive airway disease23 (27)26 (30)0.080.61
 Mediastinal radiation5 (6)6 (7)0.050.76
 Chronic liver disease/cirrhosis2 (2)5 (6)0.180.25
 Warfarin therapy35 (41)29 (35)0.130.41
 Body mass index, kg/m2 29±631±70.260.09
Echocardiographic data
 LVEF, %57±1358±110.070.64
 ≥Moderate RV dysfunction8 (10)9 (11)0.050.74
 ≥Moderate MR7 (8)8 (9)0.040.77
 RVSP ≥50 mm Hg13 (15)17 (21)0.140.36
 Mean aortic prosthesis gradient (mm Hg)16±613±5 0.47 0.002
 Aortic prosthesis EOA, cm2 1.89±0.562.21±0.67 0.52 <0.001
  • Unless otherwise specified, values are mean±SD or n (%). Statistically significant p values and standardised difference >0.3 are printed in bold. Abbreviations as per table 1.